James Duncan

Title: Innovations of James Duncan in Radiotherapy

Introduction

James Duncan is an accomplished inventor based in Richland, WA (US). He has made significant contributions to the field of radiotherapy through his innovative work. His expertise and dedication have led to the development of a unique patent that addresses critical needs in medical treatment.

Latest Patents

James Duncan holds a patent for a radiotherapy gel and method of preparing the same. This invention involves a radioactive thermogel suspension that includes a thermogel and a plurality of insoluble radioactive isotope phosphate particles, such as yttrium phosphate, suspended in the thermogel. The thermogel is composed of PLGA-g-PEG and contains less than 65 ppm stannous octanoate. The radioactive yttrium phosphate particles range in diameter from 0.03 μm to 10 μm and are generally spherical. The concentration of YPO particles is maintained between 3 mg/ml to 100 mg/ml, showcasing the precision and innovation behind his work.

Career Highlights

Throughout his career, James Duncan has demonstrated a commitment to advancing medical technology. His work at Vivos, Inc. has positioned him as a key player in the development of innovative solutions for radiotherapy. His patent reflects his ability to combine scientific knowledge with practical applications, ultimately benefiting patients in need of advanced treatment options.

Collaborations

James Duncan has collaborated with notable colleagues, including David J. Swanberg and Darrell Fisher. These partnerships have fostered an environment of innovation and creativity, allowing for the exchange of ideas and expertise in the field.

Conclusion

James Duncan's contributions to radiotherapy through his innovative patent exemplify the impact of dedicated inventors in the medical field. His work not only enhances treatment options but also showcases the importance of collaboration in driving advancements in healthcare.